CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Orchestra Biomed Fiscal Q1 2024 Earnings Report - CapyFin

Orchestra Biomed

OBIO · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q3 2025 +4.58%Q2 2025 -2.57%Q1 2025 +0.35%Q4 2024 -6.04%Q3 2024 -0.98%Q2 2024 -3.72%Q1 2024 +10.40%Q4 2023 +0.19%Q3 2023 +29.60%Q2 2023 +5.29%Q1 2023 +2.53%Q4 2022 +30.49%Q3 2022 +0.30%Q2 2022 0.00%Q1 2022 0.00%Q4 2021 0.00%Q1 2021 +3.69%

May 13, 2024

•

Mar 31, 2024

Orchestra Biomed Q1 2024 Earnings Report

Previous year: $1.16M

Previous year: -$0.4

Research and development expenses

Selling, general and administrative expenses

Interest income, net

Previous year: $1.12M

Cash and Equivalents

Previous year: $18.7M

Previous year: -$14.4M

Previous year: $136M

Orchestra Biomed

Unlock previous datapoints

Orchestra Biomed

Unlock previous datapoints

Revenue by Segment

Partnership Revenue

CapyFin.com

Product Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Orchestra Biomed

Orchestra Biomed Revenue by Segment